BXP, Inc.: BofA Global Research Raises Price Objective to $85.00 From $84.00
BXP•Related News
Ligand Pharmaceuticals, Inc. <LGND.O>: Oppenheimer Raises Target Price to $326 From $285
LGND•
Fiserv Small Business Index shows US small business sales rise 1.6% in July 2026
FI•
Gladstone Capital schedules fiscal Q3 earnings call and webcast
GLAD•
Oil prices drop after Trump cancels attack on Iran to seek deal
XLE•
Zeo Energy targets 4-5 years of growth as residential solar demand rises, CEO says
ZEO•